| 1 |
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al |
1:25-cv-00631 |
D.Del. |
|
|
|
|
| 2 |
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al |
1:25-cv-00631 |
D.Del. |
|
|
|
|
| 3 |
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al |
1:25-cv-00631 |
D.Del. |
|
|
|
|
| 4 |
AXSOME MALTA LTD. et al v. AUROBINDO PHARMA USA, INC. et al |
2:25-cv-03721 |
D.N.J. |
|
|
|
|
| 5 |
AXSOME MALTA LTD. et al v. AUROBINDO PHARMA USA, INC. et al |
2:25-cv-03721 |
D.N.J. |
|
|
|
|
| 6 |
Merck Sharp & Dohme LLC v. Aurobindo Pharma Limited et al |
1:25-cv-00449 |
D.Del. |
|
|
|
|
| 7 |
ESPERION THERAPEUTICS, INC. v. AUROBINDO PHARMA LIMITED et al |
2:24-cv-09457 |
D.N.J. |
|
|
|
|
| 8 |
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al |
2:24-cv-09209 |
D.N.J. |
|
|
|
|
| 9 |
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al |
2:24-cv-09209 |
D.N.J. |
|
|
|
|
| 10 |
INTRA-CELLULAR THERAPIES, INC. v. AUROBINDO PHARMA LTD. et al |
3:24-cv-08848 |
D.N.J. |
|
|
|
|
| 11 |
AXSOME MALTA LTD. et al v. AUROBINDO PHARMA USA, INC. et al |
2:24-cv-07511 |
D.N.J. |
|
|
|
|
| 12 |
AXSOME MALTA LTD. et al v. AUROBINDO PHARMA USA, INC. et al |
2:24-cv-07511 |
D.N.J. |
|
|
|
|
| 13 |
Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al |
1:24-cv-00698 |
D.Del. |
|
|
|
|
| 14 |
Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al |
1:24-cv-00698 |
D.Del. |
|
|
|
|
| 15 |
Pfizer Inc. et al v. Aurobindo Pharma Limited et al |
1:24-cv-00622 |
D.Del. |
|
|
|
|
| 16 |
Pfizer Inc. et al v. Aurobindo Pharma Limited et al |
1:24-cv-00622 |
D.Del. |
|
|
|
|
| 17 |
ESPERION THERAPEUTICS, INC. v. MICRO LABS USA, INC. et al |
2:24-cv-05921 |
D.N.J. |
|
|
|
|
| 18 |
ABBVIE INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al |
3:24-cv-04403 |
D.N.J. |
|
|
|
|
| 19 |
ABBVIE INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al |
3:24-cv-04403 |
D.N.J. |
|
|
|
|
| 20 |
ABBVIE INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al |
3:24-cv-04403 |
D.N.J. |
|
|
|
|
| 21 |
Bayer HealthCare LLC et al v. Aurobindo Pharma Ltd. et al |
1:24-cv-00399 |
D.Del. |
|
|
|
|
| 22 |
Bayer HealthCare LLC et al v. Aurobindo Pharma Ltd. et al |
1:24-cv-00399 |
D.Del. |
|
|
|
|
| 23 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-01182 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 24 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-01182 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 25 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-01182 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 26 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-01182 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 27 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-01182 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 28 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 29 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 30 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 31 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 32 |
Pfizer Inc. et al v. Aurobindo Pharma Limited |
1:23-cv-00923 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 33 |
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al |
1:23-cv-00582 |
D.Del. |
|
|
|
|
| 34 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 35 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 36 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 37 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 38 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 39 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
| 40 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
| 41 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
| 42 |
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED) et al |
3:23-cv-00022 |
D.N.J. |
|
|
|
|
| 43 |
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED (A.K.A. EUGIA PHARMA SPECIALTIES LIMITED) et al |
3:23-cv-00022 |
D.N.J. |
|
|
|
|
| 44 |
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01391 |
D.Del. |
|
|
|
|
| 45 |
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01391 |
D.Del. |
|
|
|
|
| 46 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
| 47 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
| 48 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
| 49 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
| 50 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|